Palliative Radiotherapy Inpatients, Outpatients, and the Changing Role of Supportive Care in Radiation Oncology

被引:5
作者
Arscott, William Tristram [1 ]
Emmett, Jaclyn [2 ]
Ghiam, Alireza Fotouhi [3 ]
Jones, Joshua A. [4 ]
机构
[1] Compass Oncol, 265 North Broadway St, Portland, OR 97227 USA
[2] Massachusetts Gen Hosp, Dept Hematol Oncol, Inpatient Oncol, 55 Fruit St, Boston, MA 02114 USA
[3] Univ British Columbia, Dept Radiat Oncol, British Columbia Canc Agcy, 2410 Lee Ave, Victoria, BC V8R 6V5, Canada
[4] Univ Penn Hlth Syst, Palliat Radiotherapy Serv, Dept Radiat Oncol, Philadelphia, PA USA
关键词
Palliative radiotherapy; Palliative care; Supportive oncology; Radiation oncology; PHASE-II TRIAL; LUNG-CANCER PATIENTS; QUALITY-OF-LIFE; LAST; 30; DAYS; BRAIN METASTASES; BONE METASTASES; AMERICAN SOCIETY; EXTERNAL VALIDATION; PREDICTIVE MODEL; THERAPY;
D O I
10.1016/j.hoc.2019.09.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Palliative radiotherapy is an effective treatment in alleviating many symptoms of advanced cancer. Short courses of radiotherapy provide rapid symptom relief and minimize impact on patients. Patients referred for palliative radiotherapy have many concerns beyond radiotherapy; often, these concerns are not fully addressed in traditional radiotherapy clinics. Discussions of prognosis, patient goals, and concerns are areas for improved collaboration. Innovative, dedicated palliative radiotherapy programs have developed over the past 20 years to provide holistic care to patients referred for palliative radiotherapy and have improved patient-focused outcomes. Advanced radiotherapy techniques may provide opportunities to further improve palliative radiotherapy outcomes.
引用
收藏
页码:253 / +
页数:27
相关论文
共 90 条
[1]   Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicity [J].
Ajgal, Z. ;
de Percin, S. ;
Dieras, V. ;
Pierga, J. Y. ;
Campana, F. ;
Fourquet, A. ;
Kirova, Y. M. .
CANCER RADIOTHERAPIE, 2017, 21 (02) :114-118
[2]   Solitary colorectal liver metastasis - Resection determines outcome [J].
Aloia, TA ;
Vauthey, JN ;
Loyer, EM ;
Ribero, D ;
Pawlik, TM ;
Wei, SH ;
Curley, SA ;
Zorzi, D ;
Abdalla, EK .
ARCHIVES OF SURGERY, 2006, 141 (05) :460-466
[3]  
Angelo K, 2014, ANTICANCER RES, V34, P877
[4]   Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG) [J].
Anker, Christopher J. ;
Grossmann, Kenneth F. ;
Atkins, Michael B. ;
Suneja, Gita ;
Tarhini, Ahmad A. ;
Kirkwood, John M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (02) :632-646
[5]  
[Anonymous], DEV RAPID ACCESS RAD
[6]  
[Anonymous], MODERN PRACTICES RAD
[7]   Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway [J].
Anshushaug, Malin ;
Gynnild, Mari Aas ;
Kaasa, Stein ;
Kvikstad, Anne ;
Gronberg, Bjorn H. .
ACTA ONCOLOGICA, 2015, 54 (03) :395-402
[8]   Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy [J].
Bang, Andrew ;
Wilhite, Tyler J. ;
Pike, Luke R. G. ;
Cagney, Daniel N. ;
Aizer, Ayal A. ;
Taylor, Allison ;
Spektor, Alexander ;
Krishnan, Monica ;
Ott, Patrick A. ;
Balboni, Tracy A. ;
Hodi, F. Stephen ;
Schoenfeld, Jonathan D. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02) :344-351
[9]   Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: A multicenter, international study [J].
Barzilai, Ori ;
Versteeg, Anne L. ;
Sahgal, Arjun ;
Rhines, Laurence D. ;
Bilsky, Mark H. ;
Sciubba, Daniel M. ;
Schuster, James M. ;
Weber, Michael H. ;
Pal Varga, Peter ;
Boriani, Stefano ;
Bettegowda, Chetan ;
Fehlings, Michael G. ;
Yamada, Yoshiya ;
Clarke, Michelle J. ;
Arnold, Paul M. ;
Gokaslan, Ziya L. ;
Fisher, Charles G. ;
Laufer, Ilya .
CANCER, 2019, 125 (05) :770-778
[10]   Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients:: acute toxicity analyses from the French multicentric study [J].
Belkacemi, Y. ;
Gligorov, J. ;
Ozsahin, M. ;
Marsiglia, H. ;
De Lafontan, B. ;
Laharie-Mineur, H. ;
Aimard, L. ;
Antoine, E. -C. ;
Cutuli, B. ;
Namer, M. ;
Azria, D. .
ANNALS OF ONCOLOGY, 2008, 19 (06) :1110-1116